InvestorsHub Logo
icon url

oneragman

08/14/20 11:05 AM

#291287 RE: Cardiologymd #291278

Cardio, agree...if it is ever a threat, it's years from now after a successful CVOT. We have more urgent hurdles to cross beforehand.
icon url

Jasbg

08/14/20 11:40 AM

#291297 RE: Cardiologymd #291278

Cardio@ Who is talking about prescribing it. It is a product under development/research (a Pipeline product).

Many see Amarin's - missing pipeline - One Drug Company - as maybe the biggest long term weakness.

This is why the possibility of something that might be a 'Product nr. 2' IMO would be great.

Jasbg